Research suggests that GLP-1 drugs may increase the risk of osteoporosis and gout, with some studies also indicating a potential higher risk of bone and tendon injuries, including fractures. The drugs, which include medications like Ozempic, may pose a silent but serious health risk. The exact nature and extent of the risks are still being reported, with some outlets citing specific increases in risk, such as a 30% increase.